Tsubota Laboratory Incorporated (TYO:4890)
Japan · Delayed Price · Currency is JPY 266.00
-7.00 (-2.56%)
Feb 16, 2026, 3:30 PM JST
Tsubota Laboratory Revenue
Tsubota Laboratory had revenue of 43.00M JPY in the quarter ending December 31, 2025, a decrease of -85.92%. This brings the company's revenue in the last twelve months to 709.82M, down -45.02% year-over-year. In the fiscal year ending March 31, 2025, Tsubota Laboratory had annual revenue of 1.36B with 101.63% growth.
Revenue (ttm)
709.82M
Revenue Growth
-45.02%
P/S Ratio
9.67
Revenue / Employee
41.75M
Employees
17
Market Cap
6.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.36B | 684.00M | 101.63% |
| Mar 31, 2024 | 673.00M | -281.00M | -29.45% |
| Mar 31, 2023 | 954.00M | 314.00M | 49.06% |
| Mar 31, 2022 | 640.00M | -47.00M | -6.84% |
| Mar 31, 2021 | 687.00M | 246.00M | 55.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ohki Healthcare Holdings | 359.41B |
| Cawachi | 285.81B |
| Qol Holdings | 281.79B |
| YAKUODO HOLDINGS | 161.03B |
| Medical System Network | 129.18B |
| Satudora Holdings | 100.84B |
| Pharmarise Holdings | 66.57B |
| Astena Holdings | 62.74B |